首页> 外文期刊>癌と化学療法 >A case of intrahepatic cholangiocarcinoma effectively treated by hepatic arterial infusion chemotherapy
【24h】

A case of intrahepatic cholangiocarcinoma effectively treated by hepatic arterial infusion chemotherapy

机译:肝动脉输液化疗有效治疗肝内胆管癌的病例

获取原文
获取原文并翻译 | 示例
           

摘要

The patient was a 50-year-old woman who suffered from gastric discomfort. She was first diagnosed as intrahepatic cholangiocarcinoma with hepatic, paraaortic lymphnodal and bone metastasis. Initial systemic chemotherapy using gemcitabine (GEM) and 5-FU failed to control the disease activity. Then she was given GEM and cisplatin (CDDP) combination chemotherapy. The response was assessed as stable disease (SD), but grade 4 leukopenia was seen. Then systemic therapy using GEM, and hepatic arterial infusion therapy with CDDP, l-leucovorin and 5-FU were continued biweekly. Partial response (PR) was achieved six months later, and her disease status was maintained as SD. This hepatic arterial infusion chemotherapy would be safe and feasible as therapy for inoperable intrahepatic cholangiocarcinoma.
机译:患者是一个50岁的女性,患有胃部不适。 她首次被诊断为具有肝,滞发淋巴结和骨转移的肝内胆管癌。 使用吉西他滨(宝石)和5-FU的初始全身化疗未能控制疾病活动。 然后她给了宝石和顺铂(CDDP)组合化疗。 响应被评估为稳定的疾病(SD),但看到4级白细胞症。 然后使用Gem的全身治疗和用CDDP,L-Leucovorin和5-Fu进行肝动脉输注治疗。 六个月后达到部分反应(PR),她的疾病状况保持为SD。 这种肝动脉输液化疗作为肝内胆管癌的疗法是安全可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号